Amicus Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference
November 12 2018 - 7:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that John F.
Crowley, Chairman and Chief Executive Officer, will present a
corporate overview at the Credit Suisse 27th Annual Healthcare
Conference in Scottsdale, Arizona on Wednesday, November 14, 2018
at 9:45 a.m. MST.
A live webcast of the presentation can be accessed through the
Investors section of the Amicus Therapeutics corporate web site at
http://ir.amicusrx.com/events-and-presentations, and will be
archived for 90 days.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-centric
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow us on Twitter and
LinkedIn.
Investors:Amicus
TherapeuticsSara Pellegrino, IRCVice President, Investor Relations
& Corporate Communicationsspellegrino@amicusrx.com(609)
662-5044
Media / Multimedia Assets:Pure
CommunicationsJennifer
Paganellijpaganelli@purecommunications.com(347) 658-8290
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Sep 2023 to Sep 2024